Laurus Labs gets USFDA approval for diabetes drug
New Delhi: Drug firm Laurus Labs said it has received approval from the US health regulator for its Metformin hydrochloride tablets used for the treatment of diabetes.
The company has received approval from the United States Food and Drug Administration (USFDA) for Metformin hydrochloride tablets USP in the strengths of 500 mg, 850 mg, and 1,000 mg, Laurus Labs said in a BSE filing.
The tablets are generic versions of Bristol-Myers Squibb Company's Glucophage tablets in the same strengths, it added.
The product and API will be commercialized from company's Unit 2 located at Atchutapuram, Visakhapatnam in Andhra Pradesh, Laurus Labs said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd